Is AngioDynamics a buy?

AngioDynamics has received a consensus rating of Buy.

When did AngioDynamics go public?

AngioDynamics is registered under the ticker NASDAQ:ANGO . Their stock opened with $11.00 in its May 27, 2004 IPO.

Where is AngioDynamics?

AngioDynamics is headquartered in Latham, NY and has 7 office locations across 4 countries.

Is Ango a buy?

AngioDynamics Inc (NASDAQ:ANGO) The 2 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 36.00, with a high estimate of 40.00 and a low estimate of 32.00. The median estimate represents a +70.98% increase from the last price of 21.06.

What are analysts’ target prices for AngioDynamics’ stock?

3 Wall Street analysts have issued 12 month target prices for AngioDynamics’ stock. Their forecasts range from $28.00 to $32.00. On average, they anticipate AngioDynamics’ stock price to reach $30.00 in the next twelve months. This suggests a possible upside of 8.3% from the stock’s current price.

Who is AngioDynamics?

Founded in 1988 in Queensbury, N.Y., U.S., AngioDynamics is today a NASDAQ-listed public company. We are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease.

How did AngioDynamics perform in fiscal 2022 Q2?

AngioDynamics (ANGO) registers strong revenue growth across the majority of its GBUs, as well as in domestic and international revenues in fiscal 2022 Q2. Angio is shifting some production to a third party in Costa Rica, but the company was adamant that its manufacturing focus would stay in upstate New York.

Where can I buy shares of Ango?

Shares of ANGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.